Related Experiment Video
Updated: Mar 24, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Digital Ulcers in Systemic Sclerosis - Frequency, Subtype Distribution and Clinical Outcome
Sevdalina Lambova1, Anastas Batalov, Lyubomir Sapundzhiev
1Medical University - Plovdiv, Department of Propedeutics in Internal medicine, Clinic of Rheumatology, Plovdiv - 4002, 15A "Vasil Aprilov" Blvd, Bulgaria. sevdalina_n@abv.bg.
Digital ulcers (DUs) are a common complication in systemic sclerosis (SSc), often affecting fingers and causing pain. Effective management requires comprehensive therapeutic strategies for positive outcomes.
Area of Science:
- Rheumatology
- Dermatology
- Vascular Medicine
Background:
- Digital ulcers (DUs) are a frequent and debilitating complication in systemic sclerosis (SSc).
- They significantly contribute to pain, hand dysfunction, and overall disability in SSc patients.
- Understanding the frequency, evolution, and treatment of DUs is crucial for patient care.
Purpose of the Study:
- To analyze the frequency, characteristics, and evolution of digital ulcers (DUs) in patients with systemic sclerosis (SSc).
- To evaluate the therapeutic strategies employed for managing DUs in this patient population.
- To identify factors influencing DU occurrence and healing.
Main Methods:
- Retrospective analysis of 60 systemic sclerosis (SSc) patients.
- Data collection on DU presence, location, type, and associated inflammation.
- Review of applied therapeutic interventions and patient outcomes over a 6-month to 6-year follow-up period.
Main Results:
- Digital ulcers (DUs) were observed in 35% of SSc patients, predominantly on fingers.
- Diffuse cutaneous SSc patients showed a higher incidence of DUs compared to limited cutaneous SSc and overlap syndrome.
- Ischemic lesions were the most common type; healing time averaged 3.39 months, with complex treatments including vasodilators, antiseptics, and antiplatelets being necessary.
Conclusions:
- Digital ulcers (DUs) represent a significant and common complication in systemic sclerosis (SSc).
- Management of DUs necessitates a multifaceted therapeutic approach.
- Early and comprehensive treatment is vital for improving outcomes and reducing disability in SSc patients with DUs.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

